On Monday, the Food and Drug Administration gave its full approval to Pfizer and BioNTech’s covid-19 vaccine, which has until now been covered under an emergency use authorization. It’s now the first of its kind approved in the U.S.—a decision that public health experts say could improve its acceptance among those…
